Clinical Trial Update: Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study [Phase 2]

View source ↗

Summary

Phase 2 trial investigating empagliflozin with ACE inhibitors for hyperfiltration in diabetes patients completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-07-24